Clover says its COVID-19 vaccine candidate 67 per cent effective in large trial
The company has a deal to supply up to 414 million doses of its COVID-19 vaccine through the global vaccine sharing scheme COVAX
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.